S
Saima M. Sidik
Researcher at Massachusetts Institute of Technology
Publications - 67
Citations - 2087
Saima M. Sidik is an academic researcher from Massachusetts Institute of Technology. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 9, co-authored 11 publications receiving 1442 citations.
Papers
More filters
Journal ArticleDOI
A Genome-wide CRISPR Screen in Toxoplasma Identifies Essential Apicomplexan Genes.
Saima M. Sidik,Diego Huet,Suresh M. Ganesan,My Hang Huynh,Timothy C. Wang,Timothy C. Wang,Armiyaw S. Nasamu,Prathapan Thiru,Jeroen P. J. Saeij,Vern B. Carruthers,Jacquin C. Niles,Sebastian Lourido +11 more
TL;DR: In this article, the authors adapted CRISPR/Cas9 to assess the contribution of each gene from the parasite Toxoplasma gondii during infection of human fibroblasts.
A Genome-wide CRISPR Screen in Toxoplasma Identifies Essential Apicomplexan Genes
Saima M. Sidik,Diego Huet,My Hang Huynh,Prathapan Thiru,Jeroen P. J. Saeij,Vern B. Carruthers,Sebastian Lourido,Suresh M. Ganesan,Armiyaw S. Nasamu,Jacquin C. Niles,Timothy C. Wang +10 more
TL;DR: The first genome-wide genetic screen of an apicomplexan parasite is presented, revealing essential functions during infection of human cells and providing broad-based functional information on T. gondii genes that will facilitate future approaches to expand the horizon of antiparasitic interventions.
Journal ArticleDOI
Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose
Jasdave S. Chahal,Omar F. Khan,Christopher L. Cooper,Justine S. McPartlan,Jonathan K. Tsosie,Lucas D. Tilley,Saima M. Sidik,Sebastian Lourido,Robert Langer,Sina Bavari,Hidde L. Ploegh,Daniel G. Anderson +11 more
TL;DR: In this article, the authors developed a rapid response, fully synthetic, single-dose, adjuvant-free dendrimer nanoparticle vaccine platform wherein antigens are encoded by encapsulated mRNA replicons.
Journal ArticleDOI
Efficient Genome Engineering of Toxoplasma gondii Using CRISPR/Cas9
TL;DR: The RNA-guided Cas9 nuclease is used to efficiently generate knockouts without selection, and to introduce point mutations and epitope tags into the T. gondii genome, which will streamline the functional analysis of parasite genes and enable high-throughput engineering of their genomes.
Journal ArticleDOI
The Toxoplasma dense granule proteins GRA17 and GRA23 mediate the movement of small molecules between the host and the parasitophorous vacuole
Daniel A. Gold,Aaron D. Kaplan,Agnieszka Lis,Glenna C.L. Bett,Emily E. Rosowski,Kimberly M. Cirelli,Alexandre Bougdour,Alexandre Bougdour,Saima M. Sidik,Josh R. Beck,Sebastian Lourido,Pascal F. Egea,Peter J. Bradley,Mohamed-Ali Hakimi,Mohamed-Ali Hakimi,Randall L. Rasmusson,Jeroen P. J. Saeij +16 more
TL;DR: GRA17 and GRA23 provide a molecular basis for PVM permeability and nutrient access and are identified as a Toxoplasma-secreted protein that localizes to the parasitophorous vacuole membrane (PVM) and mediates passive transport of small molecules across the PVM.